PERCEVAL PVS25 (UDI 08022057014719)Recalls & reported problems
Corcym Srl · DI for Perceval Size L · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08022057014719), received between Dec 17, 2021 and Sep 4, 2025 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
1 other recall cover devices cleared under the same FDA submission (P150011); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information2
- Degraded1
Patient problems
- Thrombocytopenia2
- Aortic Valve Stenosis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjurySep 4, 2025Degraded; Degraded
INFORMATION OBTAINED FROM A PUBLISHED PAPER ENTITLED: " EMERGENCY TRANSCATHETER AORTIC VALVE IN SUTURELESS VALVE REPLACEMENT FOR MANAGING CARDIOGENIC SHOCK", BY ALESSANDRO COMIS, ET AL. THE ABSTRACT INDICTED THE FOLLOWING: ¿SUTURELESS AORTIC BIOPROSTHESIS (SBVS) MAY POSE SPECIFIC CHALLENGES TO VALVE-IN-VALVE (VIV) IMPLANTATION, PARTICULARLY, IN THE SETTING OF CARDIOGENIC SHOCK WHICH REMAINS CHALLENGING AND UNDERSTUDIED. PAPER REPORTS A PATIENT WITH A SBVS DISFUNCTION, PRESENTING WITH ACUTE DECOMPENSATED HF. DESPITE INTRA-AORTIC BALLOON PUMP (IABP), CLINICAL DETERIORATION PROMPTED AN EMERGENCY TRANSCATHETER VIV. COMPUTER TOMOGRAPHY IMAGING CONFIRMED PROCEDURAL FEASIBILITY. A SELF-EXPANDING EVOLUT PRO+ VALVE WAS DEPLOYMENT FOLLOWED BY POST-DILATATION FOR UNDER EXPANSION. THE PROCEDURE RESTORED VALVE FUNCTION, AND THE PATIENT WAS WEANED OFF IABP. AT 30-DAY FOLLOW-UP, PATIENT WAS IN NYHA CLASS I WITH COMPLETE RECOVERY OF LEFT VENTRICULAR SYSTOLIC FUNCTION (EF 53%). CAREFUL CT PLANNING AND DEVICE SELECTION ARE CRITICAL. DESPITE THE LACK OF DATA IN THIS SETTING, VIV MAY REPRESENT A SAFE AND EFFECTIVE OPTION FOR HIGH-RISK PATIENTS IN CARDIOGENIC SHOCK (CS)¿. BASED ON THE FURTHER INFORMATI
Patient problems: Aortic Valve Stenosis
MAUDE report 22961137 ↗InjuryDec 17, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2021, A PERCEVAL VALVE PVS25 WAS IMPLANTED IN A PATIENT. THE PATIENT IS RECENTLY DIAGNOSED WITH PNEUMONIA AND STARTED ON ANTIBIOTIC. THE POST-OPT RECOVERY WAS PROLONGED (STILL IN ICU DUE TO THROMBOCYTOPENIA). THE PATIENT HAS BEEN UNDER OBSERVATION SINCE 1 DAY POSTOP UNTIL (B)(6) 2021. IT IS PRESENTLY UNKNOWN IF THE PATIENT RECOVERED OR IS STILL UNDER TREATMENT. THE PATIENT¿S PRE-OPERATIONAL ASSESSMENT HAS NO OTHER COMORBID CONDITION BESIDE THE OLD AGE. THE PATIENT WAS TESTED WITH A SUPPORT OF A HEMATOLOGIST AND THE RESULT TESTED NOTHING RELATED TO PATIENT'S PLATELET. THE PERCEVAL VALVE WAS SUSPECTED AS A POSSIBLE CONTRIBUTING FACTOR TO THROMBOCYTOPENIA.
Patient problems: Thrombocytopenia
MAUDE report 13030538 ↗InjuryDec 17, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2021, A PERCEVAL VALVE PVS25 WAS IMPLANTED IN A PATIENT. THE PATIENT IS RECENTLY DIAGNOSED WITH PNEUMONIA AND STARTED ON ANTIBIOTIC. THE POST-OPT RECOVERY WAS PROLONGED (STILL IN ICU DUE TO THROMBOCYTOPENIA). THE PATIENT HAS BEEN UNDER OBSERVATION SINCE 1 DAY POSTOP UNTIL (B)(6) 2021. IT IS PRESENTLY UNKNOWN IF THE PATIENT RECOVERED OR IS STILL UNDER TREATMENT. THE PATIENT¿S PRE-OPERATIONAL ASSESSMENT HAS NO OTHER COMORBID CONDITION BESIDE THE OLD AGE. THE PATIENT WAS TESTED WITH A SUPPORT OF A HEMATOLOGIST AND THE RESULT TESTED NOTHING RELATED TO PATIENT'S PLATELET. THE PERCEVAL VALVE WAS SUSPECTED AS A POSSIBLE CONTRIBUTING FACTOR TO THROMBOCYTOPENIA.
Patient problems: Thrombocytopenia
MAUDE report 13030408 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P150011. One submission often covers many models, so check the product and lot details in each record.
- Z-0716-2017 · Oct 31, 2016 · TerminatedPerceval Sutureless Aortic Heart Valve size S, Item # ICV1208, REF PVS21; Perceval Sutureless Aortic Heart Valve size M, Item # ICV1209, REF PVS23; Perceval Sutureless Aortic Heart
Other Heart-Valve, Non-Allograft Tissue devices
- INSPIRIS RESILIA AORTIC VALVE 11500AEdwards Lifesciences LLC · Heart-Valve, Non-Allograft Tissue2 deaths404 reports
- INSPIRIS RESILIA AORTIC VALVE 11500AEdwards Lifesciences LLC · Heart-Valve, Non-Allograft Tissue385 reports
- PERCEVAL PVS23Corcym Canada Corp · heart-valve, non-allograft tissue26 deaths337 reports
- MOSAIC® 305C23Medtronic, Inc. · heart-valve, non-allograft tissue327 reports
- MOSAIC® 305C25Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths324 reports
- FREESTYLE® FR995-27Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths318 reports
- FREESTYLE® FR995-29Medtronic, Inc. · heart-valve, non-allograft tissue288 reports
- FREESTYLE® FR99525Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths280 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page